United States· US:72789-383_4bc0370f-21ea-1acb-e063-6394a90ad768
Flecainide Acetate
A flecainide product containing flecainide acetate, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Flecainide is registered in 18 of 19 countries.
Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Flecainide · ATC C01BC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of flecainide costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Flecainide · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.20
- IT Italy$0.70
- ES Spain$0.61
- FR France$0.49
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLECAINIDE ACETATE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- C01BC04
- ATC class
- Flecainide
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc117278938301100 TABLET in 1 BOTTLE, PLASTIC (72789-383-01)
- ndc11727893836060 TABLET in 1 BOTTLE, PLASTIC (72789-383-60)
- ndc117278938393180 TABLET in 1 BOTTLE, PLASTIC (72789-383-93)
- ndc1172789-383-01
- ndc1172789-383-60
- ndc1172789-383-93
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
342 interactions on record for flecainide.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flecainide · interactions on record
342 records
- 42 severe
- 164 moderate
- 15 minor
- 75 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EliglustatA16AX10severe
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flecainide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlecainide 100mg tabletsDE Pharmaceuticals
- ItalyALMARYTMVIATRIS HEALTHCARE LIMITED
- CanadaAG-FLECAINIDEANGITA PHARMA INC.
- FinlandFlecainid ActavisActavis Group PTC ehf
- NetherlandsFlecainide Alkaloid-INT 100 mg tablettenAlkaloid - INT d.o.o.
- FranceFLECAINE 100 mg, comprimé sécableVIATRIS MEDICAL
- SpainAPOCARD 100 mg COMPRIMIDOSViatris Healthcare Limited
- SwedenTambocor 100 mg Tablett2care4 ApS
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Aristocor
- Belgium · Apocard Retard, Flecainide Retard Eg
- Bulgaria · Амаритон, Фелкарид
- Cyprus · Flecardia
- Czechia · Amarhyton, Amarhyton 100 Mg
- Germany · Flecadura, Flecainid
- Denmark · Flecainid Sandoz, Flecainid Stada
- Spain · Apocard, Flecainida Aurovitas
- Finland · Flecainide Orion, Tambocor
- France · Flecaine, Flecaine L.P.
- United Kingdom (Northern Ireland) · Flecainide Acetate Accord-Uk, Flecainide Acetate Brown & Burk Uk
- Greece · Amarhyton, Flecainide/Flexmed
- Croatia · Felkarid
- Ireland · Flecainide Teva, Tambocor
- Iceland · Flecainid Stada, Tambocor
- Italy · Almarytm, Flecainide Aurobindo
- Luxembourg · Apocard Retard, Flecainide Retard Eg
- Malta · Flecainide Acetate Aurobindo Pharma (Malta), Tambocor
- Netherlands · Flecainide Acetate Aurobindo, Flecainide Acetate Ratiopharm
- Norway · Flecainid Sandoz, Tambocor
- Poland · Flecainide Acetate Holsten
- Portugal · Amarhyton, Apocard
- Romania · Amarhyton, Tambocor
- Sweden · Tambocor, Tambocor Retard
- Slovenia · Felkarid
- Slovakia · Amarhyton 100 Mg, Amarhyton 50 Mg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ded2b179-56d4-40d2-b4b1-69619b83e6e8 GET /v1/drugs/ded2b179-56d4-40d2-b4b1-69619b83e6e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "FLECAINIDE ACETATE",
"productndc": "72789-383",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA210683",
"marketing_category": "ANDA"
}See everything about flecainide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.